Lilly Seeks To Block Generic Strattera Amid Appeal
Eli Lilly & Co. has asked a federal judge to block Mylan Pharmaceuticals Inc., Apotex Inc. and other generics makers from releasing their own versions of attention deficit hyperactivity disorder drug...To view the full article, register now.
Already a subscriber? Click here to view full article